3 The takeaway: Behavior change matters to people on GLP-1s, and the Noom app continues to be associated with stronger real-world GLP-1 outcomes Taken together, these findings tell a clear story: people who pair GLP-1 medication with consistent engagement in the Noom app see more success at weight loss, and, independently, they stay with the program longer
IVC reduces inflammation (as measured by C-reactive protein levels) and reduces the production of proinflammatory cytokines
Ungaro R, Mehandru S, Allen P, Peyrin-Biroulet L, Colombel J
Dietary habits exacerbate pain in FC via altered motility, while immune activation amplify food-triggered pain in IBS-C
These changes contribute to neuroinflammation, bloodbrain barrier (BBB) dysfunction, microglial activation, and neurotransmitter imbalances